论文部分内容阅读
一名身高只有1.25米的15周岁男孩子(仅相当于7岁正常儿童的身高),在哈医大一院神经外科接受了国内外首例人胚腺垂体培养细胞移植。通过监测,目前男孩子垂体功能低下症状得到初步纠正,已安全度过急性排斥反应期。 有关垂体移植研究在国外已成热点攻关项目,但迄今为止仍停留于实验室阶段。国内虽有垂体移植的报道,然而移植物仍处于组织块水平。哈医大一院神经外科在国家自然科学基金资助下,历时7
A 15-year-old boy (only the equivalent of a 7-year-old normal child), with a height of 1.25 meters, received the first human embryo pituitary culture cell transplantation in the Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University. By monitoring, the current symptoms of hypo pituitary dysfunction in boys have been initially corrected and have safely passed the acute rejection stage. Pituitary transplantation research has become a hot research project in foreign countries, but so far still remain in the laboratory stage. Although the domestic report of pituitary transplantation, however, the graft is still in the tissue block level. First Affiliated Hospital of Harbin Medical University neurosurgery funded by the National Natural Science Foundation, lasted 7